Montgomery, Rusty L
Yu, Guoying
Latimer, Paul A
Stack, Christianna
Robinson, Kathryn
Dalby, Christina M
Kaminski, Naftali
van Rooij, Eva
Funding for this research was provided by:
NIH (U01HL108642)
NIH (R01HL095397)
Article History
Received: 25 October 2013
Revised: 13 August 2014
Accepted: 20 August 2014
First Online: 19 September 2014
Conflict of interest
: RLM, CS, PAL, KR, and CD are employees, and EvR is scientific co‐founder and SAB member of miRagen Therapeutics, Inc. NK is a consultant for Biogen Idec, InterMune, Boehringer‐Ingelheim, MMI, Takeda, Vertex, Promedior Sanofi‐Aventis, and received investigator initiated grants from Gilead and Celgene outside the submitted work.